SCHEMBL8484075

SCHEMBL8484075

C=CCN(C)C/C=C/COc1ccc(-c2noc3cc(Br)ccc23)cc1

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LSS P48449 20/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9068098 1.00 LSS (0.89) LSS
SCHEMBL9068091 0.94 LSS (1.00) LSS
SCHEMBL17358773 0.94 LSS (1.00) LSS
SCHEMBL8762066 0.83 LSS (0.89) LSS
SCHEMBL8479453 0.82 LSS (0.60) LSS
SCHEMBL8761188 0.80 LSS (1.00) LSS
SCHEMBL8481577 0.80 LSS (1.00) LSS
SCHEMBL8760862 0.78 LSS (1.00) LSS
SCHEMBL8484754 0.78 LSS (0.69) LSS
SCHEMBL8484760 0.78 LSS (0.69) LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0778271-A2 Aminoalkyl-substituted benzo-heterocyclic compounds F. HOFFMANN-LA ROCHE AG (CH) 1997-06-11 EP claimed
US-5856503-A ANTICHOLESTEROL AGENTS HOFFMANN-LA ROCHE INC. (US) 1999-01-05 US disclosed
EP-0778271-A2 Aminoalkyl-substituted benzo-heterocyclic compounds F. HOFFMANN-LA ROCHE AG (CH) 1997-06-11 EP disclosed